This federal contract indefinite delivery vehicle (IDV) is a multiple-award Federal Supply Schedule (FSS) contract awarded by the Department of Veterans Affairs (VA) to Opko Pharmaceuticals LLC. The contract, valued at a ceiling of $19,469,960.00, is for the provision of drugs, pharmaceuticals, and hematology-related products under FSS contract category 65 IB. The period of performance runs from the award date of September 30, 2023 to the ultimate completion date of September 29, 2028.
Opko Pharmaceuticals LLC is a subsidiary of the parent company Opko Health, Inc., which is a diverse healthcare company focused on developing novel pharmaceutical and diagnostic technologies. Through past prime federal contract awards, Opko Health has provided testing services, including specialized lab tests and score testing, to the VA. Opko Health has also received subawards under federal grants to assist prime grantees with experiment design, data analysis, and reporting for pharmaceutical research and development.
Generated 11/22/24, 9:05 AM